论文部分内容阅读
我科自2007-10开始对乳腺癌患者进行颈内静脉插管院内输入化疗药,化疗间歇期院外携带插管的做法,未出现不良后果,但近期出现导管败血症(CRS)1例,现报道如下。1病历摘要女,52岁。经穿刺活检确诊为左乳癌,完成术前3个疗程多西他赛(艾素)+表柔比星(法玛新)方案化疗后遂在全麻下行
Our department from 2007-10 began breast cancer patients intravenous catheter chemotherapy in the hospital, intermittent chemotherapy during intubation with extra-hospital approach, there is no adverse consequences, but the recent emergence of catheter-induced sepsis (CRS) in 1 case, are reported as follows. 1 medical record summary female, 52 years old. The needle biopsy diagnosed as left breast cancer, completed the preoperative 3 courses of docetaxel (Alzheimer’s) epirubicin (Famaxin) program chemotherapy followed by general anesthesia